Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-16

FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved a supplemental application for ALVESCO (ciclesonide) submitted by Covis Pharma US, Inc. This action represents regulatory approval of the suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvesco (ciclesonide)

Snippet

SUPPL AP for ALVESCO (CICLESONIDE)